Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised staging system for NKTCL.

DelveInsight’s, “Systemic Mastocytosis Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and ...

In cancer care, accurate tools for predicting whether a tumor will spread (metastasize) can help patients receive the most ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

City of Hope researchers have co-led the first study to demonstrate that characterizing genetic material near chromosomes ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...